<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Decision to use or omit premedications in an individual receiving IVIG</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Decision to use or omit premedications in an individual receiving IVIG</h1>
<div class="graphic"><div class="figure"><div class="ttl">Decision to use or omit premedications in an individual receiving IVIG</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Infection should be treated <strong>before</strong> initiating IVIG when feasible. Individuals with immunodeficiencies who have a possible concomitant infection may experience chills or rigors with the initial IVIG infusion. Refer to UpToDate for other important aspects of IVIG administration.</div><div class="graphic_footnotes"><p>IVIG: intravenous immune globulin; NSAID: nonsteroidal antiinflammatory drug; SCIG: subcutaneous immune globulin; IgA: immunoglobulin A.</p>
<p>* We generally avoid premedication in individuals who have not previously received IVIG or those who have not had an allergic or other mild reaction, as many individuals will tolerate IVIG without premedications, and this practice avoids unnecessary medications in many cases. An alternative approach, also reasonable, is to give premedications with the first dose, and, if no reaction occurs, omit them with subsequent doses. Patient values and preferences should be assessed.</p>
<p>¶ When premedications are used, we generally start with an NSAID, acetaminophen, and/or an antihistamine. Migraine prophylaxis may be reasonable for certain individuals. Glucocorticoids may also be reasonable; however, we generally avoid glucocorticoids, especially in individuals with immunodeficiency, reserving them for individuals for whom other approaches are ineffective. For individuals receiving regular IVIG infusions with premedications, it may be reasonable to reevaluate the need for premedications periodically.</p>
Δ Other approaches besides premedication include:
<ul>
<li>Using a slower initial infusion rate.</li>
<li>Switching to an SCIG product if appropriate.</li>
<li>Changing IVIG products.</li>
<li>In some cases with low or absent IgA and a prior reaction, switching to a low IgA product such as Gammagard SD may be reasonable.</li>
<li>If the reaction was in the distant past (eg, years prior) it may be reasonable to reevaluate the need for premedications, either by performing a test dose without premedications or by gradually decreasing premedications and observing closely for a reaction.</li>
</ul>
These and other approaches are discussed in more detail in UpToDate.</div><div id="graphicVersion">Graphic 130102 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
